The Patent Finder

Terms ending in 2037

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2037, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,125,134Kras G12C Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,633,381Kras G12C Inhibitors
In force
 · High confidence
Array BioPharma Inc.In forceHigh confidence
US 10,647,715Kras G12C Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,689,377Kras G12C Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 11,267,812Kras G12C Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 11,214,571Process for the Preparation of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide and Salts Thereof
In force
 · High confidence
Array BioPharma Inc.In forceHigh confidence
US 10,485,788Pharmaceutical Combinations
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,112,942Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · Medium confidence
Array Biopharma Inc.In forceMedium confidence
US 10,137,124Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · Medium confidence
Array Biopharma Inc.In forceMedium confidence
US 10,144,734Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
7 more term ends in 2037 · Pro
10 of 17 patents shown. Soonest term end first, then patent number.
Pro members see all 17.
Upgrade to Pro
16 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited